Previous Article | Next Article 
Journal of Clinical Microbiology, May 2000, p. 1953-1958, Vol. 38, No. 5
0095-1137/00/$04.00+0
Rapid Identification of Yersinia
enterocolitica in Blood by the 5' Nuclease PCR Assay
Keya
Sen*
Division of Emerging and Transfusion
Transmitted Diseases, Center for Biologics Evaluation and Research,
Food and Drug Administration, Rockville, Maryland 20852
Received 14 December 1999/Returned for modification 20 January
2000/Accepted 23 February 2000
 |
ABSTRACT |
Yersinia enterocolitica accounts for 50% of the
clinical sepsis episodes caused by the transfusion of contaminated red
blood cells. A 5' nuclease TaqMan PCR assay was developed to detect Y. enterocolitica in blood. Primers and a probe based on
the nucleotide sequence of the 16S rRNA gene from Y. enterocolitica were designed. Whole-blood samples were spiked
with various numbers of Y. enterocolitica cells, and total
chromosomal DNA was extracted. When the TaqMan PCR assay was performed,
as few as six bacteria spiked in 200 µl of blood could be detected.
The assay was specific and did not detect other Yersinia
species. The TaqMan assay is easy to perform, takes 2 h, and has
the potential for use in the rapid detection of Y. enterocolitica contamination in stored blood units.
 |
INTRODUCTION |
Yersinia enterocolitica,
a gram-negative bacterium, is responsible for 50% of all the clinical
sepsis episodes that occur as a result of transfusion of contaminated
red blood cells (RBCs) (19). It is the major bacterial
contaminant found in RBC concentrates, and the result of such
contamination has proven to be fatal in 61% of all the reported cases
of Y. enterocolitica sepsis resulting from transfusion
(19). Pseudomonas fluorescens is responsible for
a further 26% of the transfusion-associated sepsis episodes. Serratia liquefaciens has become another major bacterial
pathogen to contaminate blood product units, and since 1992, five cases have been reported to the Centers for Disease Control and Prevention (27). Other bacteria implicated in RBC contamination are
Pseudomonas putida, Campylobacter jejuni,
Enterobacter jejuni, Escherichia coli, and
Flavobacterium (32). The ability of Y. enterocolitica to contaminate RBCs can be attributed to its being
a psychrophilic bacterium that can survive well at refrigerator
temperatures, using dextrose and iron from the blood. Thus, packed red
cells, which are usually stored at 4°C for up to 42 days, can allow
the growth of these bacteria (32). The bacteria go through
an initial lag period of 7 to 32 days during storage at 4°C and then
show exponential growth, with an 18- to 20-h doubling time (3, 8, 18, 29, 32). Y. enterocolitica secretes an endotoxin,
which is probably responsible for much of the morbidity and mortality (9). While the bacterium may lose its virulence during
storage, since the plasmid that encodes virulence factors that lead to cellular invasion and resistance to the complement-mediated lysis is
often lost during storage (19, 24), the endotoxin released and the bacterium itself act as sources of toxicity. Conventional methods for detection of this bacterium in blood include detection of
the endotoxin it produces by the Limulus amebocyte lysate
assay (30) and staining of the bacterial cells with
hematologic stains such as acridine orange or Giemsa or Wright-Giemsa
(10, 23). However, the identity of the bacterium cannot be
established by these methods. In addition, these methods depend on the
growth of the bacteria to a density of 104 to
106 CFU per ml, a level that may take several days to
achieve. A PCR-based assay for detection of Y. enterocolitica in blood was described by Feng et al.
(11). They could detect 500 bacteria seeded in 100 µl of
blood, or 5,000 bacteria/ml. This was a significant improvement in the
detection sensitivity and specificity and suggested that PCR could be
useful for detecting bacterial contamination in stored blood units.
This assay, however, may not be able to detect early contamination,
when only a few bacteria are present in blood. Therefore, newer nucleic
acid-based methodology was sought, to achieve this level of detection sensitivity.
The 5' nuclease fluorogenic TaqMan assay has been recently described
(21). The method exploits the property of Taq
polymerase to act as a 5'-3' exonuclease (15). Briefly, an
oligonucleotide probe that has a reporter fluorescent dye attached to
its 5' end and a quencher dye attached to its 3' end is used in the
assay. Initially, the unbound probe is not able to emit a fluorescent signal because of the proximity of the reporter and quencher dyes. When
the probe hybridizes to its target template, the reporter dye is
cleaved by the 5' nuclease activity of Taq polymerase and becomes capable of emitting a fluorescent signal without the
suppression activity of the quencher dye. With increasing cycles of
amplification more fluorescent signal is generated by binding of the
probe to more available target, which can be detected in real time by
the ABI 7700 sequence detector (PE Applied Biosystems, Foster City, Calif.). The sequence detector contains a thermocycler, laser detection
system, and analysis software system. Analysis of the signal takes only
about a minute after the PCR is completed. Because the generation of
the fluorescent signal depends on the hybridization of the probe to a
specific template, which is being amplified, there is less scope for
false signals from nonspecific amplification. It is necessary to detect
a very few bacteria in blood, which may have contaminated a unit, in
order to avoid a sepsis reaction, and this assay seemed to have the
potential for such detection. In this report, a TaqMan PCR assay is
described which is rapid and shows specific and sensitive detection of
Y. enterocolitica in blood.
 |
MATERIALS AND METHODS |
Bacterial species and culture conditions.
Y.
enterocolitica isolates of serotypes Y288, O:3, O:1,2,3, O:5,27,
and O:20 were obtained from P. Feng (Food and Drug Administration, Washington, D.C.). Serotypes O:3, O:1,2,3, O:5,27, and O:20 were previously implicated in blood endotoxemia resulting from transfusion (30). The bacteria were grown in brain heart infusion (BHI) broth (Sigma, St. Louis, Mo.) at 30°C, with continuous shaking. O:3
was used in serial dilution and spiking of sodium citrate-preserved human whole blood. O:3 was grown to an optical density at 600 nm of 0.6 and then diluted in phosphate-buffered saline. Typically, 10-µl
aliquots were spiked into 190 µl of blood. Another 10 µl was plated
on BHI agar to determine the viable cell count. The number of bacteria
spiked in the 10-µl volume ranged from 4 to 100,000. Other bacterial
species used are listed in Table 1.
Preparation of DNA.
Chromosomal DNA was prepared from spiked
blood by the QIAamp blood kit (Qiagen Corp., Santa Clarita, Calif.) or
the Dynabeads DNA Direct system II kit (Dynal, Oslo, Norway). For the
QIAamp blood kit, 190 µl of blood was spiked with a 10-µl volume
containing 5 to 100,000 bacteria. Proteinase K and the ALW buffer
supplied in the kit were added, and the protocol was followed exactly
as specified by the manufacturer. DNA was extracted in a final volume of 100 µl of Tris-Cl, pH 8. For the Dynal kit, 2 to 50,000 bacteria in a 5-µl volume were spiked into 95 µl of blood. The DNA was extracted in a final volume of 75 µl. When comparisons between the
two kits were done, a 400-µl sample was spiked with bacteria; a
200-µl aliquot of this was used for the QIAamp blood kit and 100 µl
was used for the Dynal kit. Total DNA was also extracted from overnight
cultures of different Y. enterocolitica strains by the
Puregene kit (Gentra, Minneapolis, Minn.). In addition, chromosomal DNA
was prepared from other bacterial species by Midi Labs (Newark, Del.),
using the Puregene kit. Plasmid DNA was purified with the Wizard
Miniprep DNA purification kit (Promega, Madison, Wis.).
Design of primers and probes.
The 16S rRNA gene has been
sequenced from several Y. enterocolitica strains. All the
available partial and full-length 16S rRNA gene sequences from GenBank
were aligned, and the conserved sequences were identified, by the
PileUp program of the Genetics Computer Group (Madison, Wis.) software
package. The approximate location of the specific probe was first
determined. This was done by searching the GenBank databases for
uniqueness of the probe to Y. enterocolitica 16S ribosomal
DNA (rDNA), using the BLAST database search program (2). The
final selection of the primers and the exact length of the probe were
determined, using the ABI Primer Express program (PE Applied
Biosystems). This program selects probe and primer sets with optimized
melting temperatures, secondary structure, base composition, and
amplicon lengths. The length of the amplicon is an important
consideration in the sensitivity and the reproducibility of the assay.
The forward primer, 16SF, had the sequence
5'CGGCAGCGGGAAGTAGTTT3', and the reverse primer, 16SR, had
the sequence 5'GCCATTACCCCACCTACTAGCTAA3'. Both of these primers recognized 16S rDNA sequences from all Y. enterocolitica strains. The primers were made by the Biotechnology
Core Facility, Center for Biologics Evaluation and Research, Food and
Drug Administration, and amplified a fragment of 201 bp spanning
nucleotides 47 to 247 of the 16S rRNA gene (accession no. Z49830). The
TaqMan fluorescent probe YE1 had the sequence
5'FAM-AAGGTCCCCCACTTTGGTCCGAAG-TAMRA3' and was made by PE
Applied Biosystems. It was located from nucleotides 166 to 190 (reverse
complement) of the 16S rRNA gene of Y. enterocolitica. FAM
(6-carboxyfluorescein) is the reporter dye, and TAMRA
(6-carboxytetramethylrhodamine) is the quencher dye. The 3' end
was phosphorylated to prevent extension by Taq polymerase.
TaqMan assay.
Reactions were performed in 50-µl volumes in
0.5-ml optical-grade PCR tubes (PE Applied Biosystems). Each 50 µl of
reaction mixture contained a 400 nM concentration of primers, an 80 nM concentration of the probe, 200 µM (each) dTTP, dUTP, dATP, and dGTP,
1 U of AmpliTaq Gold polymerase, and 1× PCR buffer (10× supplied with
the enzyme). MgCl2 was added to a final concentration of 3 mM when the Puregene kit was used to extract the DNA from pure cultures
and was added to a final concentration of 5 mM when either the QIAamp
or the Dynal kit was used to isolate the DNA from blood. When the
QIAamp blood kit was used to extract the DNA, 20 µl of the template
was added, and 30 µl was used when DNA was isolated by the Dynal kit.
Cycling conditions consisted of an initial single cycle at 95°C for
10 min to activate AmpliTaq Gold, followed by 40 to 50 cycles of
two-temperature cycling consisting of 15 s at 95°C and 1 min at
60°C. PCR was performed with the ABI 7700 sequence detector, as per
instructions in the instrument's manual.
Post-PCR analysis.
Data were analyzed by SDS software (PE
Biosystems). The software calculates a value for
Rn using the
equation
Rn = Rn+
Rn
.
Rn+ is the emission intensity of the reporter divided by
the emission intensity of the quencher at any given time in a reaction
tube; Rn
is the emission intensity of the reporter
divided by the emission intensity of the quencher of the same reaction
prior to PCR amplification. The
Rn values were plotted on the
y axis, and the time, represented by the cycle number, was
plotted on the x axis. The threshold cycle (CT)
value is the noninteger calculation of the number of cycles required
for the reporter dye fluorescence to become significantly higher than
the background, which can happen when a sufficient amount of the
hybridization probe has been cleaved (12, 14). This will
also indicate the increased formation of the PCR product. The
CT values for each reaction were automatically calculated by the default parameters of the program. As expected, the
amplification plots shift to the right, to higher CT
values, with diminishing numbers of template copies.
The correct size of the PCR product from each assay was verified by
running a sample from each reaction tube on agarose gels stained with
ethidium bromide.
 |
RESULTS |
Theoretical detection limit by TaqMan PCR.
In order to
determine the sensitivity of the assay, pure chromosomal DNA from
serotype O:3 was isolated by the Puregene kit from overnight cultures
of bacteria grown in BHI medium at 30°C. TaqMan PCR was performed by
using 100 ng to 1 fg of chromosomal DNA as a template and the primers
and probes described above. A DNA concentration of
5 fg could be
detected (Fig. 1). Since the size of the
Y. enterocolitica genome is not known, this number could not
be used to calculate the exact number of bacteria that could be
detected. However, based on the size of the Yersinia pestis
genome, which is 4,398 kb (22), and that of the
Yersinia ruckeri genome, which is 4,460 to 4,770 kb
(26), if we assume the size of the Y. enterocolitica genome to be 4,400 kb, then 5 fg of DNA would
amount to approximately one genome. If there were 1 copy of the 16S
rRNA gene per cell, this would translate to 1 template, or 10 templates
if there were 10 copies of the gene per cell, and so on. The 201-bp PCR
fragment was also cloned into E. coli using the TopoTA
cloning vector pCR 2.1-Topo, of a length of 3.9 kb, from the Topo TA
cloning kit (Invitrogen Corp., Carlsbad, Calif.). When the plasmid
pKSY, having a length of 4.101 kb (3.9 + 0.201 kb) and containing
the cloned insert, was used as a template, the detection limit was
0.0061 fg. This number amounted to a copy number of 1.3. This was
calculated as follows: 4.101 kb is equal to 2.7 × 106
g/mol, and 0.006 fg of a 4.101-kb plasmid would contain 2.2 × 10
24 mol. Multiplying this number by Avogadro's number,
6 × 1023, gives the number of molecules or the copy
number value of 1.3. Thus, the primers and the probe combination as
well as the length of the amplicon which was being amplified were
optimal, since the greatest TaqMan PCR sensitivity could be achieved,
which was 1 CFU.

View larger version (86K):
[in this window]
[in a new window]
|
FIG. 1.
Detection limit of the TaqMan assay for Y. enterocolitica. Chromosomal DNA from a pure culture of serotype
O:3 was isolated as described in Materials and Methods. Quantities of
100 ng, 10 ng, 1 ng, 100 pg, 10 pg, 1 pg, 100 fg, 5 fg, and 1 fg,
represented by amplification plots 1 to 9, respectively, were used as
template in each 50 µl of PCR mixture. The gel inset shows 5 µl of
the corresponding product from each reaction, which was examined on a
2.5% agarose gel. Lane M is the molecular size standard, consisting of
a 50-kb DNA ladder. Lanes 1 to 9 correspond to plots 1 to 9. The arrow
indicates the position of the 201-bp product obtained as a result of
amplification of the region from nucleotides 47 to 247 of the 16S rRNA
gene with primers 16SF and 16SR.
|
|
Specificity of TaqMan PCR.
The specificity of the TaqMan PCR
assay for Y. enterocolitica strains was examined by
isolating genomic DNA from five different Y. enterocolitica
strains. In PCR assays, 20 ng of this pure DNA was used. A
CT value in the range from 18.2 to 20.9 was obtained with
each of the Y. enterocolitica strains (Fig.
2; Table 1). When 200-ng samples of
chromosomal DNA from the related species Yersinia
frederiksenii and Yersinia pseudotuberculosis were
used, the CT values obtained were 45 (Fig. 2; Table 1). The
CT values were also 45 when two other major bacteria that
contaminate RBC units, P. fluorescens and S. liquefaciens, were examined by this set of primers and probe (Fig.
2; Table 1). The TaqMan probe YE1, in addition to recognizing all
Y. enterocolitica strains, also showed 100% homology with
16S rDNA of Hafnia alvei, some Serratia spp., and
Erwinia spp. TaqMan PCR was therefore done with chromosomal
DNA isolated from H. alvei, Serratia ficaria, and
Serratia grimesii. The CT values obtained were
45. The primers and probe could not be tested with Erwinia
species because a sample chromosomal DNA could not be obtained. But it
is unlikely that the assay would recognize Erwinia species
because a set of three oligonucleotides is used in the TaqMan assay,
and for a positive reaction, all three would have to show substantial
homology. Thus, even though Y. frederiksenii showed 100%
homology with the forward primer and 84% homology with the reverse
primer, since the probe did not show any major sequence homology, the
CT value was 45 (Fig. 2; Table 1).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 2.
Specificity of the TaqMan assay for Y. enterocolitica. Chromosomal DNAs (20 ng each) from five Y. enterocolitica serotypes (Y288; O:1,2,3; O:3; O:5,27; and O:20)
were used as templates in TaqMan PCR, and their amplifications are
represented in plots 1 to 5, respectively. The gel inset shows the
201-bp product from each PCR, and lanes 1 to 5 correspond to plots 1 to
5. The arrow indicates the position of the 201-bp product. Chromosomal
DNAs (200 ng each) from seven other bacterial species listed in Table 1
were also tested with primers 16SF and 16SR and probe YE1, and their
amplifications are represented in plots 6 to 12. The cycle numbers are
on the x axis.
|
|
Blood samples.
Logarithmic-phase Y. enterocolitica
O:3 cells were spiked into blood at different concentrations. Six
different kits were tried initially for extraction of the total DNA,
containing DNA from blood and bacteria. The DNA extracted by the QIAamp
kit and the Dynal kit proved to be equivalent for the TaqMan assay
(Fig. 3). In addition, both methods were
fast; they took only 20 min for extraction of the DNA. In four
different spiking experiments, the minimum threshold of detection was
six bacteria spiked into 200 µl of blood. Representative data, of a
dilution series with 6 to 6,000 bacteria spiked into 200 µl of blood,
are shown in Fig. 3. The CT values obtained typically were
between 36 and 37. Optimization experiments were performed initially,
to choose the right probe concentration and magnesium concentration, so
that the highest
Rn values were obtained without compromising the specificity of the signal. The cutoff CT value was taken to
be 39, and any signal higher than this was not considered a positive signal because the unspiked blood sometimes gave a signal at a CT value of 40. However, in these samples the
Rn value
was less than 0.05.

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 3.
Detection limit of the TaqMan assay for Y. enterocolitica in blood samples. Different amounts of Y. enterocolitica cells were spiked into blood, and the total DNA was
isolated as described in Materials and Methods. (A) Bacteria were
spiked into 200 µl of blood, and DNA was isolated by the QIAamp blood
kit in a final volume of 100 µl. The corresponding numbers of cells
spiked are as follows: plot 1, none (unseeded blood); plot 2, 30 cells/ml (1.2 cell equivalent/50 µl of PCR mixture); plot 3, 60 cells/ml (2.4 cell equivalent/50 µl of PCR mixture); plot 4, 300 cells/ml; plot 5, 3,000 cells/ml; and plot 6, 30,000 cells/ml. The gel
inset shows the products obtained, and lanes 1 to 6 correspond to plots
1 to 6. Lane 7 is a no-template control. (B) Bacteria were spiked into
100 µl of blood, and DNA was extracted by the Dynal DNA Direct kit in
a final volume of 75 µl. The corresponding cell numbers are as
follows: plot 1, none (unseeded blood); plot 2, 30 cells/ml (1.2 cell
equivalent/PCR mixture); plot 3, 300 CFU/ml (12 cell equivalents/PCR
mixture); plot 4, 3,000 cells; and plot 5, 30,000 cells. The gel inset
represents the products obtained, and lanes 1 to 5 correspond to plots
1 to 5. M is the 50-bp molecular size DNA ladder, and the arrow
indicates the 201-bp product.
|
|
 |
DISCUSSION |
The need to identify a very small number of bacteria in blood that
is to be transfused is critical. In this report the development of a
PCR-based 5' nuclease assay to detect a small number of Y. enterocolitica organisms in blood is described. The use of PCR to
identify the presence of microbial DNA in a variety of clinical specimens has been reported by several laboratories (4, 17, 25). A factor that has limited the use of PCR-based diagnostic methods to detect microbial contamination in blood directly is the
inhibitory effects of blood on Taq polymerase. This includes the hemoglobin in blood itself and the preservatives used to store blood (1, 33). In this study several DNA extraction methods have been evaluated. Furthermore, since the DNA extracted was to be
used in an assay measuring fluorescence, some of the extraction methods
needing the use of reagents that quenched fluorescence had to be
eliminated. Both the QIAamp blood kit and the Dynal DNA kit proved to
be superior in providing DNA suitable for the assay. The results with
the QIAamp blood kit appeared to be more reproducible from day to day.
In PCR methods, if the template targeted is in several copies then the
sensitivity of the assay should increase, which in this case would
translate into detection of fewer CFU of bacteria. In bacteria there
are several copies of the 16S rRNA gene (28), and therefore
this gene was chosen over the invasion gene ail, the
virF gene present in the virulence plasmid pYV, or the
heat-stable enterotoxin (yst) gene, which have been used by
other groups (13, 16, 20). The detection threshold in blood
using the virF and ail genes was 5,000 bacteria/ml (11). The pYV plasmid is often lost during
storage and growth and therefore is not suitable as a target
(24). Although the ail and the yst
genes are specific for virulence and would be present only in a
pathogenic strain, it was argued that the presence of any species of
Y. enterocolitica would be reason for removing a blood unit.
The goal was to achieve the greatest sensitivity with respect to the
number of bacteria detected, regardless of whether the strain was
pathogenic or not. Targeting of the 16S rRNA gene by a seminested PCR
approach has also been used by another group recently (31).
Their method's detection level was 100 CFU/ml. However, their samples
were from pure bacterial cell suspensions. The present assay was able
to detect 5 fg of Y. enterocolitica bacterial DNA from pure
cultures, which would be equivalent to 1 CFU and to 30 CFU of Y. enterocolitica per ml of blood. The assay could be developed
further by increasing the efficiency of the purification of DNA from
blood or by concentrating the extracted DNA. As of now, 20 µl of DNA
out of a final volume of 100 µl, extracted by the QIAamp kit, was
used per PCR. This would amount to 1.2 bacteria per 50 µl of PCR
mixture, if originally 6 bacteria were spiked into 200 µl of blood.
The question of whether the in vitro spiking experiments represent the
true viability of bacteria in blood has not been addressed in this
assay. The TaqMan PCR assay, using DNA as a template, cannot
distinguish between live and dead bacteria. Use of the TaqMan assay in
reverse transcription-PCR, using the 16S rRNA as a template, may be
able to detect live bacteria. With this reverse transcription-PCR
assay, one could then hope to study the viability of bacteria in blood.
Since the 16S rRNA gene has regions of conserved sequences in all
bacterial species, targeting the ubiquitous sequences on this template
by PCR has some inherent problems. Contamination of samples by bacteria
from the laboratory environment or by translocation of bacterial DNA
from the gut to the blood could lead to false positives. Precautions
were taken to use sterile reagents and conditions wherever possible.
Dedicated pre- and post-PCR pipettes and rooms were used. The PCR
reagents were added in a UV-irradiated hood. It is unlikely other
bacterial species would be detected by this assay, since the assay uses
three oligonucleotides; all of them would have to have substantial
homology with the template being amplified. Thus, even though the
TaqMan probe and the reverse primer show 100% homology with the
corresponding region of 16S rDNA of H. alvei, no signal was
generated when the TaqMan PCR was performed with this set of
oligonucleotides. The same was true with S. grimesii.
However, the unspiked blood sometimes showed an unspecific
amplification around cycle 40. Increasing the annealing temperature to
62°C or changing the forward and reverse primer set did not solve the
problem. However, the
Rn was very small in the unspiked blood.
Although a detection sensitivity of 6 bacteria/200 µl (30 bacteria/ml) of blood is better than that for any previously published methods, this assay still perhaps cannot be used to test donors or
donated blood on day 0 or 1. However, it can be used for testing of
blood shortly after it is processed or during the early days of
storage. The earliest time at which this detection level would be
useful remains to be established.
The initial cost for equipment may pose a problem for the widespread
use of this method. However, technological advances are being made, and
smaller, field-oriented thermocyclers and spectrofluorometers, which
use silicon chips, are being developed (6). The advanced nucleic acid analyzer recently described by Belgrader et al.
(7), besides cutting the assay time to minutes and being
portable, would also help decrease the cost. It is also easily
adaptable to automation. Furthermore, with increased use of nucleic
acid testing for detection of viral markers in blood, the technical base for such molecular testing is already being developed and will
soon be in place.
In conclusion, the TaqMan assay is rapid and eliminates the use of
multiplex PCR, Southern blotting, or agarose gel electrophoresis. The
entire test can be completed in 3 h, which includes the DNA extraction step. In addition, only 100 to 200 µl of blood is needed for analysis. Coupled with the current development of automated systems
for DNA preparation that are capable of handling DNA from 96 blood
samples, such as the QIAamp BioRobot 9604 and QIAamp 9600 Biorobot
kits, this assay could be considered for incorporation into
high-throughput testing.
 |
ACKNOWLEDGMENTS |
I thank Soren Kamstrup, Chiang Syin, Paul Mied, Ursula Utz, Mary
Beth Jacobs, Stephen Wagner, and Gilliam Conley for helpful discussions
and critical reading of the manuscript.
 |
FOOTNOTES |
*
Mailing address: Division of Emerging and Transfusion
Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, HFM-320, 1401 Rockville Pike, Rockville, MD 20852. Phone: (301) 594-6752. Fax: (301) 594-6989. E-mail: Senk{at}cber.fda.gov.
 |
REFERENCES |
| 1.
|
Akane, A.,
K. Matsubara,
H. Nakamura,
S. Takahashi, and K. Kimura.
1994.
Identification of the heme compound copurified with deoxyribonucleic acid (DNA) from bloodstains, a major inhibitor of polymerase chain reaction (PCR) amplification.
J. Forensic Sci.
39:362-372[Medline].
|
| 2.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 3.
|
Arduino, M. J.,
L. A. Bland,
M. A. Tipple,
S. M. Aguero,
M. S. Favero, and W. R. Jarvis.
1989.
Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes.
J. Clin. Microbiol.
27:1483-1485[Abstract/Free Full Text].
|
| 4.
|
Backman, A.,
P. Lantz,
P. Radstrom, and P. Olcen.
1999.
Evaluation of an extended diagnostic PCR assay for detection and verification of the common causes of bacterial meningitis in CSF and other biological samples.
Mol. Cell. Probes
13:49-60[CrossRef][Medline].
|
| 5.
|
Bassler, H. A.,
S. J. A. Flood,
K. J. Livak,
J. Marmaro,
R. Knorr, and C. A. Batt.
1995.
Use of a fluorogenic probe in a PCR-based assay for the detection of Listeria monocytogenes.
Appl. Environ. Microbiol.
61:3724-3728[Abstract].
|
| 6.
|
Belgrader, P.,
W. Benett,
D. Hadley,
J. Richards,
P. Stratton,
R. Mariella, Jr., and F. Milanovich.
1999.
PCR detection of bacteria in seven minutes.
Science
284:449-450[Free Full Text].
|
| 7.
|
Belgrader, P.,
W. Benett,
D. Hadley,
G. Long,
R. Mariella, Jr.,
F. Milanovich,
S. Nasarabadi,
W. Nelson,
J. Richards, and P. Stratton.
1998.
Rapid pathogen detection using a microchip PCR array instrument.
Clin. Chem.
44:2191-2194[Abstract/Free Full Text].
|
| 8.
|
Bradley, R. M.,
R. M. Gander,
S. K. Patel, and H. S. Kaplan.
1997.
Inhibitory effect of 0 degree C storage on the proliferation of Yersinia enterocolitica in donated blood.
Transfusion
37:691-695[CrossRef][Medline].
|
| 9.
|
Buchholz, D. H.,
J. P. AuBuchon,
E. L. Snyder,
R. Kandler,
S. Edberg,
V. Piscitelli,
C. Pickard, and P. Napychank.
1992.
Removal of Yersinia enterocolitica from AS-1 red cells.
Transfusion
32:667-672[CrossRef][Medline].
|
| 10.
|
Centers for Disease Control and Prevention.
1991.
Epidemiologic notes and reports update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red blood cell transfusions United States, 1991.
Morb. Mortal. Wkly. Rep.
40:176-178[Medline].
|
| 11.
|
Feng, P.,
S. P. Keasler, and W. E. Hill.
1992.
Direct identification of Yersinia enterocolitica in blood by polymerase chain reaction amplification.
Transfusion
32:850-854[CrossRef][Medline].
|
| 12.
|
Gibson, U. E.,
C. A. Heid, and P. M. Williams.
1996.
A novel method for real time quantitative RT-PCR.
Genome Res.
6:995-1001[Abstract/Free Full Text].
|
| 13.
|
Harnett, N.,
Y. P. Lin, and C. Krishnan.
1996.
Detection of pathogenic Yersinia enterocolitica using the multiplex polymerase chain reaction.
Epidemiol. Infect.
117:59-67[Medline].
|
| 14.
|
Heid, C. A.,
J. Stevens,
K. J. Livak, and P. M. Williams.
1996.
Real time quantitative PCR.
Genome Res.
6:986-994[Abstract/Free Full Text].
|
| 15.
|
Holland, P. M.,
R. D. Abramson,
R. Watson, and D. H. Gelfand.
1991.
Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.
Proc. Natl. Acad. Sci. USA
88:7276-7280[Abstract/Free Full Text].
|
| 16.
|
Ibrahim, A.,
W. Liesack,
M. W. Griffiths, and R. M. Robins-Browne.
1997.
Development of a highly specific assay for rapid identification of pathogenic strains of Yersinia enterocolitica based on PCR amplification of the Yersinia heat-stable enterotoxin gene (yst).
J. Clin. Microbiol.
35:1636-1638[Abstract].
|
| 17.
|
Kane, T. D.,
J. W. Alexander, and J. A. Johannigman.
1998.
The detection of microbial DNA in the blood: a sensitive method for diagnosing bacteremia and/or bacterial translocation in surgical patients.
Ann. Surg.
227:1-9[CrossRef][Medline].
|
| 18.
|
Kim, D. M.,
M. E. Brecher,
L. A. Bland,
T. J. Estes,
S. K. McAllister,
S. M. Aguero,
R. A. Carmen, and E. J. Nelson.
1992.
Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters.
Transfusion
32:658-662[CrossRef][Medline].
|
| 19.
|
Klein, H. G.,
R. Y. Dodd,
P. M. Ness,
J. A. Fratantoni, and G. J. Nemo.
1997.
Current status of microbial contamination of blood components: summary of a conference.
Transfusion
37:95-101[CrossRef][Medline].
|
| 20.
|
Kwaga, J.,
J. O. Iversen, and V. Misra.
1992.
Detection of pathogenic Yersinia enterocolitica by polymerase chain reaction and digoxigenin-labeled polynucleotide probes.
J. Clin. Microbiol.
30:2668-2673[Abstract/Free Full Text].
|
| 21.
|
Livak, K. J.,
S. J. Flood,
J. Marmaro,
W. Giusti, and K. Deetz.
1995.
Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.
PCR Methods Appl.
4:357-362[Medline].
|
| 22.
|
Lucier, T. S., and R. R. Brubaker.
1992.
Determination of genome size, macrorestriction pattern polymorphism, and nonpigmentation-specific deletion in Yersinia pestis by pulsed-field gel electrophoresis.
J. Bacteriol.
174:2078-2086[Abstract/Free Full Text].
|
| 23.
|
McCarthy, L. R., and J. E. Senne.
1980.
Evaluation of acridine orange stain for detection of microorganisms in blood cultures.
J. Clin. Microbiol.
11:281-285[Abstract/Free Full Text].
|
| 24.
|
Miller, V. L.,
J. J. Farmer III,
W. E. Hill, and S. Falkow.
1989.
The ail locus is found uniquely in Yersinia enterocolitica serotypes commonly associated with disease.
Infect. Immun.
57:121-131[Abstract/Free Full Text].
|
| 25.
|
Morris, T.,
B. Robertson, and M. Gallagher.
1996.
Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system.
J. Clin. Microbiol.
34:2933-2936[Abstract].
|
| 26.
|
Romalde, J. L.,
I. Iteman, and E. Carniel.
1991.
Use of pulsed field gel electrophoresis to size the chromosome of the bacterial fish pathogen Yersinia ruckeri.
FEMS Microbiol. Lett.
68:217-225[CrossRef][Medline].
|
| 27.
| Roth, V. R., M. Arduino, J. Nobiletti, S. Holt, L. Carson, C. E. F. Wolf, B. Lenes, P. Allison, and W. R. Jarvis. Transfusion-related sepsis due to Serratia
liquefaciens in the United States. Transfusion, in press.
|
| 28.
|
Smith, T. J.,
M. Maher,
F. Gannon, and M. T. Dawson.
1995.
Development of bacterial species-specific DNA probes based on ribosomal RNA genes using PCR.
Methods Mol. Biol.
46:247-256[Medline].
|
| 29.
|
Stenhouse, M. A., and L. V. Milner.
1982.
Yersinia enterocolitica. A hazard in blood transfusion.
Transfusion
5:396-398[CrossRef].
|
| 30.
|
Tipple, M. A.,
L. A. Bland,
J. J. Murphy,
M. J. Arduino,
A. L. Panlilio,
J. J. Farmer III,
M. A. Tourault,
C. R. Macpherson,
J. E. Menitove, and A. J. Grindon.
1990.
Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica.
Transfusion
30:207-213[CrossRef][Medline].
|
| 31.
|
Trebesius, K.,
D. Harmsen,
A. Rakin,
J. Schmelz, and J. Heesemann.
1998.
Development of rRNA-targeted PCR and in situ hybridization with fluorescently labelled oligonucleotides for detection of Yersinia species.
J. Clin. Microbiol.
36:2557-2564[Abstract/Free Full Text].
|
| 32.
|
Wagner, S. J.,
L. I. Friedman, and R. Y. Dodd.
1994.
Transfusion-associated bacterial sepsis.
Clin. Microbiol. Rev.
7:290-302[Abstract/Free Full Text].
|
| 33.
|
Yokota, M.,
N. Tatsumi,
O. Nathalang,
T. Yamada, and I. Tsuda.
1999.
Effects of heparin on polymerase chain reaction for blood white cells.
J. Clin. Lab. Anal.
13:133-140[CrossRef][Medline].
|
Journal of Clinical Microbiology, May 2000, p. 1953-1958, Vol. 38, No. 5
0095-1137/00/$04.00+0
This article has been cited by other articles:
-
Sen, K., Schable, N. A., Lye, D. J.
(2007). Development of an Internal Control for Evaluation and Standardization of a Quantitative PCR Assay for Detection of Helicobacter pylori in Drinking Water. Appl. Environ. Microbiol.
73: 7380-7387
[Abstract]
[Full Text]
-
Matsuda, K., Tsuji, H., Asahara, T., Kado, Y., Nomoto, K.
(2007). Sensitive Quantitative Detection of Commensal Bacteria by rRNA-Targeted Reverse Transcription-PCR. Appl. Environ. Microbiol.
73: 32-39
[Abstract]
[Full Text]
-
Brecher, M. E., Hay, S. N.
(2005). Bacterial Contamination of Blood Components. Clin. Microbiol. Rev.
18: 195-204
[Abstract]
[Full Text]
-
Dreier, J., Stormer, M., Kleesiek, K.
(2004). Two Novel Real-Time Reverse Transcriptase PCR Assays for Rapid Detection of Bacterial Contamination in Platelet Concentrates. J. Clin. Microbiol.
42: 4759-4764
[Abstract]
[Full Text]
-
Ott, S. J., Musfeldt, M., Ullmann, U., Hampe, J., Schreiber, S.
(2004). Quantification of Intestinal Bacterial Populations by Real-Time PCR with a Universal Primer Set and Minor Groove Binder Probes: a Global Approach to the Enteric Flora. J. Clin. Microbiol.
42: 2566-2572
[Abstract]
[Full Text]
-
Fukushima, H., Tsunomori, Y., Seki, R.
(2003). Duplex Real-Time SYBR Green PCR Assays for Detection of 17 Species of Food- or Waterborne Pathogens in Stools. J. Clin. Microbiol.
41: 5134-5146
[Abstract]
[Full Text]
-
Fredriksson-Ahomaa, M., Korkeala, H.
(2003). Low Occurrence of Pathogenic Yersinia enterocolitica in Clinical, Food, and Environmental Samples: a Methodological Problem. Clin. Microbiol. Rev.
16: 220-229
[Abstract]
[Full Text]
-
Wannet, W. J. B., Reessink, M., Brunings, H. A., Maas, H. M. E.
(2001). Detection of Pathogenic Yersinia enterocolitica by a Rapid and Sensitive Duplex PCR Assay. J. Clin. Microbiol.
39: 4483-4486
[Abstract]
[Full Text]
-
Okeke, C. N., Tsuboi, R., Ogawa, H.
(2001). Quantification of Candida albicans Actin mRNA by the LightCycler System as a Means of Assessing Viability in a Model of Cutaneous Candidiasis. J. Clin. Microbiol.
39: 3491-3494
[Abstract]
[Full Text]
-
Ge, Z., White, D. A., Whary, M. T., Fox, J. G.
(2001). Fluorogenic PCR-Based Quantitative Detection of a Murine Pathogen, Helicobacter hepaticus. J. Clin. Microbiol.
39: 2598-2602
[Abstract]
[Full Text]